We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Shire Sues IMPAX Over ANDA for Adderall Generic

Law360 (December 30, 2003, 12:00 AM EST) -- Shire Laboratories Inc., a subsidiary of Shire Pharmaceuticals Group, filed a lawsuit in the U.S. District Court for the District of Delaware against IMPAX Laboratories over IMPAX’ plans to make a generic version of Shire’s Adderall drug for attention deficit hyperactivity disorder (ADHD) in children.

The lawsuit results from an abbreviated new drug application (ANDA) filed by IMPAX for a generic version of 30 mg Adderall XR. In the filing, IMPAX provided notice that it would seek to market its generic product before the expiration of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.